- CA$27.77m
- CA$18.34m
- CA$45.12m
Brief: Medipharm Labs Enters United States Pharmaceutical Market With Submission Of FDA Dmf
Brief: Medipharm Labs Provides Operational Update And Confirms Profitability Improvement Initiatives Are Underway
Brief: MediPharm Labs Announces Changes To Board Of Directors
Brief: Medipharm Labs Expands CBN Portfolio With Two New Products
Canada Research Roundup: Medipharm Labs, Exchange Income, Propel Holdings
Brief: Medipharm Reports Third Quarter 2021 Results, Announces New CEO To Start Today
Brief: Medipharm Labs Appoints New Chief Executive Officer
Brief: Insomnia Treatment Study Using Medipharm Labs Cbd50 Product To Proceed To Phase 2 With Health Canada Consent
Brief: MediPharm Labs Australia Receives Government Grant To Assist With International Expansion
MediPharm Labs up on shipping approval for medical cannabis oil to Brazil
Brief: MediPharm Labs Receives Approval To Ship Cannabis Oil To Brazil
Canada Research Roundup: Auxly Cannabis Group, Equitable Group, Stelco Holdings
Brief: Medipharm Labs Enters Research Agreement With Mcmaster University To Develop Drugs Containing Cannabis Candidates
Canada Research Roundup: Bank of Montreal, Questor Technology, Royal Bank of Canada
Brief: Medipharm Labs Corp Posts Qtrly Net Loss Of $0.07 Per Share
Brief: Medipharm Labs Achieves Export Milestone, Ships Cannabis Oil From Australia To Germany
Brief: European Pharmaceutical Company STADA And Medipharm Labs Begin First Sales In Germany Under Exclusive Agreement
Canada Research Roundup: Dollarama, Park Lawn, Telus
Brief: Medipharm Labs Reports Qtrly Revenue Of $6.1 Mln Increased 22% Compared To $4.9 Mln In Q3 2020